| Product Code: ETC12838659 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Mauritius continued to rely on key suppliers such as India, Metropolitan France, Germany, Turkey, and the UK for its influenza medications imports. The market exhibited a shift from high concentration in 2023 to moderate concentration in 2024, indicating a more diversified import market. Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) over the period of 2020-2024 remained positive at 4.71%, reflecting steady demand for influenza medications in Mauritius. This trend suggests a stable market with opportunities for both existing and potential suppliers to capitalize on.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Influenza Medications Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Influenza Medications Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Influenza Medications Market - Industry Life Cycle |
3.4 Mauritius Influenza Medications Market - Porter's Five Forces |
3.5 Mauritius Influenza Medications Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Mauritius Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Mauritius Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
4 Mauritius Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius Influenza Medications Market Trends |
6 Mauritius Influenza Medications Market, By Types |
6.1 Mauritius Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Influenza Medications Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Mauritius Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2021 - 2031F |
6.1.4 Mauritius Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2021 - 2031F |
6.2 Mauritius Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Influenza Medications Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Mauritius Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2021 - 2031F |
6.2.4 Mauritius Influenza Medications Market Revenues & Volume, By Inhalation, 2021 - 2031F |
6.3 Mauritius Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Influenza Medications Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Mauritius Influenza Medications Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Mauritius Influenza Medications Market Revenues & Volume, By Geriatric, 2021 - 2031F |
7 Mauritius Influenza Medications Market Import-Export Trade Statistics |
7.1 Mauritius Influenza Medications Market Export to Major Countries |
7.2 Mauritius Influenza Medications Market Imports from Major Countries |
8 Mauritius Influenza Medications Market Key Performance Indicators |
9 Mauritius Influenza Medications Market - Opportunity Assessment |
9.1 Mauritius Influenza Medications Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Mauritius Influenza Medications Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Mauritius Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
10 Mauritius Influenza Medications Market - Competitive Landscape |
10.1 Mauritius Influenza Medications Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here